Adverts
MORRISVILLE, North Carolina, also May 19, 2022 /PRNewswire/ -- Metabolon, Inc., an international leader in delivering metabolomics solutions that advance drug engineering and precision medicine, has named Sean Iverson Vice President of International Advertising . As part of the management group, Iverson will lead the marketing approach and execution of the company's expanding product portfolio.
“Sean’s continued birth of information-driven effects in the life sciences will help Metabolon’s product solutions pipeline and should expand and accelerate our market impact across the board,” said Rohan Hastie, Ph.D., President and CEO of Metabolon. “We are excited to welcome him to the organization. His experience encompasses solid insight into the biotechnology and lifestyle sciences industries, bringing an imperative point of view to our viewers and helping our consumers maximize our suite of options to achieve their analytics dreams.”
One of Iverson's priorities is to expand the company's portfolio to include a full suite of visually dynamic, easy-to-consider metabolomics options that convey insight into disorder associations and biological topics. Metabolon's proprietary Heliogram™ visualization tool enables clients to discover important pathways for rapid connectivity to the effects of therapeutic interventions.
“As a market leader in metabolomics, Metabolon has the chance to drive improvements across the entire scope of life sciences,” noted Iverson. “Scientific research and drug construction come with financial chance and uncertainty. Metabolon's innovative options enable complete insight into disease states and expose wonderful insights into human health. I am excited to be part of the Metabolon group.”
Iverson drove success in his previous roles by emphasizing analytics and marketing efforts, and records-driven products with incredible industrial consequences. Most recently, Iverson was vice president of international advertising at Sophia Genetics, leading the company's business expansion and digital advertising and marketing, branding and public family members. He also became actively concerned about the company's initial public offering. Iverson also served in management roles at Danaher and Cisco systems.
Iverson earned his MBA in international advertising and marketing from Santa Clara University's Leavey School of Company. Additionally, he holds an MA in International Family Members from the Johns Hopkins University School of Advanced International Experiences and a BA in Political Science and Asian Reviews from Brigham Young University.
About Metabolon Metabolon, Inc. is a global leader in metabolomics, with a mission to bring biochemical records and insights that expand and accelerate the influence of life sciences research. With more than 20 years, more than 10,000 tasks, more than 2,800 publications and ISO 9001:2015 and CLIA certifications, Metabolon has developed scientific, technological and bioinformatics techniques. Metabolon's Precision Metabolomics™ platform is enabled with the help of the kingdom's largest proprietary metabolomics reference library. Metabolon's market-leading information and translational science advantage help valued customers and partners tackle one of the most difficult and urgent crucial questions within the life sciences, accelerating research and increasing construction success. The company features scalable, customizable metabolomics and lipidomics options that support customer needs from discovery to medical testing and product lifecycle management. For extra tips, please discuss with metabolon.Com and follow us on LinkedIn and Twitter.
About MetabolomicsMetabolomics, the large-scale examination of all small molecules in a biological system, is the best 'omics technology that provides a useful readout of the entire existing state of a biological device. Metabolomics helps researchers see beyond people's genetic variation, capturing the combined effects of genetics as well as external components such as the impact of drugs, weight loss plan, culture and microbiome on human fitness. By measuring many discrete chemical signals that form organic pathways in the body, metabolomics can display essential biomarkers, enabling a better understanding of a drug's mechanism of action, pharmacodynamics and protective profile, as well as individual responses to treatment.
